April 2024
Starting from:
£99 + VAT
Format: DOWNLOADABLE PDF
This conference discussed next steps for NICE in delivering innovation and supporting clinical practice in health and social care in England.
It brought stakeholders together with policymakers to evaluate progress on key ambitions outlined in the NICE Strategy 2021 to 26, and next steps for guideline development following publication of Transforming NICE.
Delegates discussed the role of NICE in the development of new approaches and models of healthcare, including:
- developing guidance around integrated care following the Health and Care Act 2022
- new preventative and personalised models of healthcare being developed as part of the Major Conditions Strategy
- addressing NHS challenges, including recent guidance around the use of virtual wards to support capacity within hospitals
Discussion considered use of real-world evidence, new approaches to health technology evaluation, and improving patient access to innovative treatments.
Further sessions looked at NICE’s future role in improving patient outcomes, tackling health inequalities, providing value for money and safeguarding the use of new technologies.
We are pleased to have been able to include keynote sessions with: Dr Clare Morgan, Director of Implementation and Partnerships, NICE; Dr Sarah Byron, Programme Director, Devices, Diagnostics and Digital, NICE; and Sarah Jenner, Principal, IQVIA.
Overall, areas for discussion included:
- priorities for 5-year strategy: next steps and key issues for strategy delivery - driving development and adoption of innovative and cost-effective health technologies to improve patient outcomes
- transforming NICE: exploring ways to better meet user needs and adapt to changes in healthcare - improving care while keeping it affordable and effective
- real-world evidence framework:
- utilising data for insight into healthcare delivery, patient experience and intervention outcomes - progress and next steps for research and innovation
- ensuring that data-driven approaches are safe and reliable in order to enable use in real-world situations - measuring impact - implementation of Secure Data Environments (SDEs)
- evaluation: taking forward new approaches to assessing health technology - priorities for supporting efficient adoption of new developments - improving patient access to medicines
- innovation: utilising new technologies and data-driven approaches to improve outcomes - options for preventative and personalised care models - developing approaches for the use of AI
- reducing pressures: the supporting role of NICE guidelines in tackling backlogs in the NHS - priorities for virtual wards, care pathways and community care
- collaboration: strategies and frameworks for increased co-working between the NHS, the research industry and academia
- social impact: developing guidelines to better support key societal priorities - health inequalities - patient access and safety - increasing treatment options across a diverse range of conditions
The conference was an opportunity for stakeholders to consider the issues alongside key policy officials who attended from DHSC; DoH, NI; MHRA; OHID; UK NSC; DBT; GLD; HMPPS; HM Treasury; The Scottish Government; and the Welsh Government.
